IBM’s AI cybersecurity platform Watson now available for Indian firms
Category: #business  By Pankaj Singh  Date: 2019-08-26
  • share
  • Twitter
  • Facebook
  • LinkedIn

IBM’s AI cybersecurity platform Watson now available for Indian firms

IBM has reportedly started the provision of their AI powered platform Watson, to detect and resolve cybersecurity threats faced by organizations in India.

Cybercrime has become a massive source of organized crime in the 21st century, in India as well as across the globe. Reports suggest that the global economy will face a loss of over $2 trillion by the year 2021, making it the biggest threat to companies worldwide.

A recent study by IBM-Ponemon Institute shows that nearly 79% of firms in India do not have a CSIRP (computer security incident response plan) for security across operations. The 2019 reports also suggest that the threat scenario for breaches has risen considerably and continues to rise at an alarming rate.

Organizations traditionally hire a team of cybersecurity experts to ensure the safety of their data, either associated with vendor companies or through direct employment. The IBM Watson platform will enable Indian companies to safeguard their data against breaches and theft through an automated cybersecurity system rather than relying on a manual workforce.

According to a report by Nasscom, DSCI and PwC, cybersecurity is projected to be valued at approximately $35 billion by 2025, which will create over a million jobs and facilitate nearly 1,000 startups.

IBM’s Artificial Intelligence platform Watson for Cybersecurity will save IT teams in Indian forms a considerable amount of time by detecting cyber threat scenarios nearly 50% faster than other security systems. Artificial Intelligence is the future of cybersecurity and is currently the most efficient way to safeguard data and sensitive information against cyber criminals.

IBM Watson uses machine learning and natural language processing technologies, which help train the system to comprehend the language of security.

In addition to other cutting-edge facilities, IBM Watson has the ability to automatically detect and classify sensitive information and reveal risks related to compliance. The system can also monitor data access, recognize anomalies, and prevent loss of data with comprehensive data monitoring across files, databases, Hadoop distributions, NoSQL platforms and more.

Source Credit: https://www.business-standard.com/article/companies/ibm-offers-ai-platform-watson-to-indian-companies-to-keep-hackers-at-bay-119082600013_1.html

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Pankaj Singh    

Pankaj Singh

With an experience as an insurance underwriter and a freelance writer under his belt, Pankaj Singh boasts of quite some expertise in the field of content creation. A qualified Post Graduate in Management, Pankaj has also completed a detailed course in Digital Marketin...

Read More

More News By Pankaj Singh

Rocket Pharma unveils Phase 1/2 trial data for its Fanconi Anemia drug
Rocket Pharma unveils Phase 1/2 trial data for its Fanconi Anemia drug
By Pankaj Singh

The manuscript includes data of the first four trial participants that were treated with RP-L102 under the Phase 1/2 FANCOLEN-I study.   First RP-L102 trail data demonstrates increase in bone marrow engraftment levels, which further leads to...

Shopify buys 6 River Systems for $450M to grow its fulfillment network
Shopify buys 6 River Systems for $450M to grow its fulfillment network
By Pankaj Singh

Acquisition of 6 River Systems seems to be an attempt to accelerate the growth in delivery of daily packages. The deal would further expand the reach of the Shopify Fulfillment Network, which utilizes machine learning to ensure lower shipping cost...

Genentech to present new data from neuroscience portfolio at ECTRIMS
Genentech to present new data from neuroscience portfolio at ECTRIMS
By Pankaj Singh

The data from the neuroscience portfolio would be showed at the 35th ECTRIMS between September 11 and 13 in Stockholm.   The presentations would include entire Phase III outcomes from the SAkuraStar trial investigating satralizumab as a Neur...